Get the Stockscreener App
2.61
0.00%
0.04
Intelligent Bio Solutions Inc stock is traded at $2.61, with a volume of 1,416.
It is up +0.00% in the last 24 hours and up +46.41% over the past month.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
See More
Previous Close:
$2.65
Open:
$2.66
24h Volume:
1,416
Relative Volume:
0.02
Market Cap:
$8.06M
Revenue:
$3.91M
Net Income/Loss:
$-11.65M
P/E Ratio:
-0.2118
EPS:
-12.3212
Net Cash Flow:
$-11.51M
1W Performance:
-4.33%
1M Performance:
+46.41%
6M Performance:
-41.89%
1Y Performance:
-81.97%
1-Day Range:
$2.66
$2.70
1-Week Range:
$2.60
$3.49
52-Week Range:
$1.52
$24.90
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Name
Intelligent Bio Solutions Inc
Sector
Industry
Phone
646-790-5756
Address
135 W 41ST ST,, NEW YORK
Compare INBS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
2.67 | 8.06M | 3.91M | -11.65M | -11.51M | -12.32 |
ABT
Abbott Laboratories
|
114.68 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.90 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.28 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.62 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.50 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Intelligent Bio Solutions Inc Stock (INBS) Latest News
Intelligent Bio Solutions completes clinical data collection for FDA 510(k) - scanx.trade
INBS Looks 0.4% Overvalued on GF Value™ - GuruFocus
Intelligent Bio Solutions Revenue Rises 38% to $4.2 Million in Fiscal 2026 - Moomoo
Intelligent Bio Solutions resolves all cybersecurity review items ahead of H2 2026 FDA filing - scanx.trade
Intelligent Bio Solutions revenue rises 38% to $4.2 million - grafa.com
BRIEF-Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth - Bitget
Form 8K Intelligent Bio Solutions Inc For: 19 August By Investing.com - Investing.com Nigeria
Intelligent Bio Solutions Inc. Reports Earnings Results for the Full Year Ended June 30, 2026 - marketscreener.com
INBS FY26 Results: Revenue up 38% to $4.2M, margin expands to 48.6% - scanx.trade
Intelligent Bio Solutions Revenue Jumps 38% as Gross Margin Expands 778 Basis Points - Minichart
Intelligent Bio Solutions | 10-K: Annual report - Moomoo
Intelligent Bio Solutions Reports Fiscal 2026 Revenue Up 38% to $4.22M, Gross Margin 48.63% - TradingView
INBS: Revenue up 38% to $4.2M, gross margin 48.63%, FDA submission on track for late 2026 - TradingView
INTELLIGENT BIO SOLUTIONS INC. FY 2026: Revenue $4.22M, EPS $(8.44) — 10-K Summary - TradingView
Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth - TradingView
Intelligent Bio (NASDAQ: INBS) warns on cash and survival - Stock Titan
Intelligent Bio Solutions grows to 502 customers as net loss widens to $12.5M - Stock Titan
Intelligent Bio Solutions (NASDAQ:INBS): Can Commercial Adoption Accelerate? - Kalkine Media
Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action? - Benzinga
Intelligent Bio Solutions receives ISO 13485:2016 recertification - Investing.com
Intelligent Bio Solutions receives ISO 13485:2016 recertification By Investing.com - Investing.com Canada
Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification - The Manila Times
A Fingerprint Drug Test Aligns With the FDA's New Regulation—What's Next? - Stock Titan
What Should Readers Watch in Intelligent Bio Solutions (NASDAQ:INBS) as Diagnostic Adoption Comes Into Focus? - Kalkine Media
INBS Drops 7.67% to $2.77 as Intelligent Bio Solutions Approaches Key SupportNews Sentiment - Vinanet
Intelligent Bio Solutions (INBS) gets 5.91% ownership update from Armistice Capital - Stock Titan
Intelligent Bio Solutions (INBS) Surges 15.35% to $2.93 — Testing Key Resistance at $3.08Skew Index - Vinanet
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Form 8K Intelligent Bio Solutions Inc For: 11 August By Investing.com - Investing.com Canada
Intelligent Bio Solutions Advances FDA Fingerprinting Drug Study - TipRanks
Intelligent Bio Solutions completes multi-site study, targets FDA 510(k) submission in H2 2026 - TradingView
Intelligent Bio Solutions Inc. (INBS) stock price, news, quote and history - Yahoo Finance Singapore
INBS Looks 48.6% Undervalued on GF Value™ but Faces Challenges - GuruFocus
Intelligent Bio Solutions completes FDA clinical study program By Investing.com - Investing.com Australia
Intelligent Bio Solutions completes FDA clinical study program - Investing.com
Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System - The Manila Times
Intelligent Bio Solutions Completes Method Comparison Study for the Intelligent Fingerprinting Drug Screening System - marketscreener.com
INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership - Stocktwits
Intelligent Bio Solutions (INBS) Slips 1% as Shares Test Key Support at $1.86Equal Weight ETF - Vinanet
INBS Q1 2025 Earnings: Deeper-Than-Expected Loss Highlights Persistent Cost PressureMargin Expansion Trends - Vinanet
Intelligent Bio Solutions Inc (INBS) Stock News Today - TradingKey
Intelligent Bio Solutions Inc (INBS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
INBS Q4'26 Earnings: revenue estimate is 1.22M USD - TradingView
Intelligent Bio Solutions Completes Usability Study For Intelligent Fingerprinting Drug Screening System Supporting FDA 510(k) Submission - marketscreener.com
Intelligent Bio Solutions Advances Fingerprint Drug Screening Program - TipRanks
Intelligent Bio Solutions completes usability study for FDA filing - Investing.com
Intelligent Bio Solutions completes usability study for FDA filing By Investing.com - Investing.com India
Intelligent Bio Solutions Completes Usability Study for Fingerprinting Drug Screen; 510(k) on Track - TradingView
Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission - The Manila Times
15 Operators Used Intelligent Bio Solutions' Drug Test Without Lab Training - Stock Titan
Intelligent Bio Solutions Expands Share Count Through Equity Transactions - tipranks.com
Intelligent Bio Solutions Inc Stock (INBS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.59%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):